Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
Author
Oncology Times
Published
Mon 04 Mar 2024
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP64_022724.mp3.mp3
Share to:
